As the third most common malignancy and the second most deadly cancer, colorectal cancer (CRC) induces estimated 1.9 million incidence cases and 0.9 million deaths worldwide in 2020. An accurate CRC subtype classification system is of great significance for basic research and clinical outcome.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via OpenAlex.
| Category | 🧬 Medicine & Biology |
| Published | Jul 06, 2021 |
| Journal | Translational Oncology |
| Authors | Yue Xi, Pengfei Xu |
| DOI | 10.1016/j.tranon.2021.101174 |
| Citations | 2,433 |
| Source | OpenAlex |